Skip to content
DataLookout
Menu

IMPACTNCT06644963

IMPELLA, Complications and Tolerance

StatusUnknown
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Hemocompatibility related adverse events (HRAEs)
Timeframe: From start of hospitalization until hospital discharge, assessed up to 3 month

Secondary (5)

Early mortality
Adverse events related to Impella devices
Duration of mechanical ventilation
Lengh of stay
Cardiac long-term project

Arms and interventions

Devices: Impella (5, 5.5 or CP)

Sites

1 site in 1 country

  • Montpellier university hospitalMontpellier, France